Search Results - "Natividad Cuende"

Concise Review: Bone Marrow Mononuclear Cells for the Treatment of Ischemic Syndromes: Medicinal Product or Cell Transplantation? by Cuende, Natividad, Rico, Laura, Herrera, Concha

“…The Committee for Advanced Therapies of the European Medicines Agency recently classified autologous bone marrow‐derived mononuclear cells and CD133+ stem…”
Get full text

Andalusian Initiative for Advanced Therapies: Fostering Synergies by Cuende, Natividad

“…The Iniciativa Andaluza en Terapias Avanzadas (Andalusian Initiative for Advanced Therapies; IATA) is a publicly funded organization promoted by the Regional…”
Get full text

Meeting the Shortage of Human Cells and Tissues: The Andalusian Quality Assurance Programme for Tissue Donation by Alvarez-Marquez, Antonia José, Huet, Jesus, Pérez-Villares, José Miguel, Daga-Ruiz, Domingo, Diaz-Aunión, Concepción, Castro de la Nuez, Pablo, Cuende, Natividad

“…A quality assurance programme for the tissue donation process was launched in Andalusia in 2020 to facilitate the integration of tissue donation into…”
Get full text

Successful restoration of corneal surface integrity with a tissue-engineered allogeneic implant in severe keratitis patients by González-Gallardo, Carmen, Martínez-Atienza, Juliana, Mataix, Beatriz, Muñoz-Ávila, José Ignacio, Daniel Martínez-Rodríguez, J., Medialdea, Santiago, Ruiz-García, Antonio, Lizana-Moreno, Antonio, Arias-Santiago, Salvador, de la Rosa-Fraile, Manuel, Garzon, Ingrid, Campos, Antonio, Cuende, Natividad, Alaminos, Miguel, González-Andrades, Miguel, Mata, Rosario

“…Corneal diseases are among the main causes of blindness, with approximately 4.6 and 23 million patients worldwide suffering from bilateral and unilateral…”
Get full text

Histological assessment of nanostructured fibrin-agarose skin substitutes grafted in burnt patients. A time-course study by Martin-Piedra, Miguel Angel, Carmona, Gloria, Campos, Fernando, Carriel, Víctor, Fernández-González, Ana, Campos, Antonio, Cuende, Natividad, Garzón, Ingrid, Gacto, Purificación, Alaminos, Miguel

“…A previously developed fibrin-agarose skin model-UGRSKIN-showed promising clinical results in severely burnt patients. To determine the histological parameters…”
Get full text

When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes by Cuende, Natividad, Herrera, Concha, Keating, Armand

Get full text

Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol by Romero, Miguel, Suárez-de-Lezo, José, Herrera, Concha, Pan, Manuel, López-Aguilera, José, Suárez-de-Lezo, Jr, José, Baeza-Garzón, Flor, Hidalgo-Lesmes, Francisco Javier, Fernández-López, Olga, Martínez-Atienza, Juliana, Cebrián, Eva, Martín-Palanco, Vanesa, Jiménez-Moreno, Rosario, Gutiérrez-Fernández, Rosario, Nogueras, Sonia, Carmona, Maria Dolores, Ojeda, Soledad, Cuende, Natividad, Mata, Rosario

“…Cellular therapies have been increasingly applied to diverse human diseases. Intracoronary infusion of bone marrow-derived mononuclear cells (BMMNC) has…”
Get full text

Regulation of advanced therapies in Europe: Are we on the right track? by Izeta, Ander, Cuende, Natividad

“…Sixteen years after regulating advanced therapy medicinal products (ATMPs) in the European Union, few ATMPs have gained marketing authorization. Additionally,…”
Get full text

Spanish Congress of Transplant Coordinators 2018 by Cuende, Natividad

Get full text

Towards a sustainable pricing of pharmaceutical goods by Ciccocioppo, Rachele, Cuende, Natividad

Get full text

Clinical Translation of Stem Cell Therapies: A Bridgeable Gap by Cuende, Natividad, Izeta, Ander

“…Stem cell scientists trying to reach patients often lack the multidisciplinary skills needed to overcome complex regulatory barriers and may feel deterred from…”
Get full text

Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products by Cuende, Natividad, Ciccocioppo, Rachele, Forte, Miguel, Galipeau, Jacques, Ikonomou, Laertis, Levine, Bruce L., Srivastava, Alok, Zettler, Patricia J.

“…Hospital exemption (HE) is a regulated pathway that allows the use of advanced therapy medicinal products (ATMPs) within the European Union (EU) under…”
Get full text

Cell, tissue and gene products with marketing authorization in 2018 worldwide by Cuende, NATIVIDAD, RASKO, JOHN E.J, KOH, MICKEY B.C, DOMINICI, MASSIMO, IKONOMOU, LAERTIS

“…Abstract Cell and gene therapies (CGTs) are progressively entering into clinical practice in different parts of the world. The International Society for Cell &…”
Get full text

Addressing Risks Derived From the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide by Cuende, Natividad, Vilarrodona, Anna, Vuelta, Elena, Marazuela, Rosario, Herrera, Concha, Querol, Sergi, Sánchez-Ibáñez, Jacinto, Carmona, Mar, Gayá, Antonio, Tort, Jaume, Hernández, Dolores, Domínguez-Gil, Beatriz

“…In view of the public consultation recently launched by the World Health Organization on Regulatory Convergence of Cell and Gene Therapy Products and the…”
Get full text

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study by Fernández, Oscar, Izquierdo, Guillermo, Fernández, Victoria, Leyva, Laura, Reyes, Virginia, Guerrero, Miguel, León, Antonio, Arnaiz, Carlos, Navarro, Guillermo, Páramo, Maria Dolores, Cuesta, Antonio De la, Soria, Bernat, Hmadcha, Abdelkrim, Pozo, David, Fernandez-Montesinos, Rafael, Leal, Maria, Ochotorena, Itziar, Gálvez, Patricia, Geniz, Maria Angeles, Barón, Francisco Javier, Mata, Rosario, Medina, Cristina, Caparrós-Escudero, Carlos, Cardesa, Ana, Cuende, Natividad

“…Currently available treatments for secondary progressive multiple sclerosis(SPMS) have limited efficacy and/or safety concerns. Adipose-mesenchymal derived…”
Get full text

Transplant of Tissue-Engineered Artificial Autologous Human Skin in Andalusia: An Example of Coordination and Institutional Collaboration by Egea-Guerrero, Juan Jose, Carmona, Gloria, Correa, Elena, Mata, Rosario, Arias-Santiago, Salvador, Alaminos, Miguel, Gacto, Purificacion, Cuende, Natividad

“…A new model of tissue-engineered artificial autologous human skin developed in Andalusia is currently being transplanted into patients suffering from large…”
Get full text

How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation by Cuende, José I., Cuende, Natividad, Calaveras-Lagartos, Javier

“…Aims In 2008, a new cardiovascular risk table from the Framingham Heart Study was published, which incorporated the new concept ‘vascular age’. The aim of the…”
Get full text

Addressing Risks Derived From the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide by Cuende, Natividad, Vilarrodona, Anna, Vuelta, Elena, Marazuela, Rosario, Herrera, Concha, Querol, Sergi, Sánchez-Ibáñez, Jacinto, Carmona, Mar, Gayá, Antonio, Tort, Jaume, Hernández, Dolores, Domínguez-Gil, Beatriz

“…In view of the public consultation recently launched by the World Health Organization on Regulatory Convergence of Cell and Gene Therapy Products and the…”
Get full text

Santander Global Summit in Transplantation: Supporting Global Convergence in the Shared Goals of Sufficiency, Transparency, and Oversight by Domínguez-Gil, Beatriz, López-Fraga, Marta, Muller, Elmi, Potena, Luciano, Martin, Dominique E, Pérez Blanco, Alicia, Van Assche, Kristof, Oniscu, Gabriel C, Chatzixiros, Efstratios, Jha, Vivekanand, Miñambres, Eduardo, Cuende, Natividad, Forsythe, John L R, Gardiner, Dale, Nagral, Sanjay, Tullius, Stefan G, Cooper, Matthew, Delmonico, Francis L

Get full text

Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived Therapies by Cuende, Natividad, Tullius, Stefan G, Izeta, Ander, Plattner, Verena, Börgel, Martin, Ciccocioppo, Rachele, Correa-Rocha, Rafael, Koh, Mickey B C, De Angelis, Vincenzo, Gondolesi, Gabriel E, Ten Ham, Renske, Porte, Robert J, Hernández-Maraver, Dolores, Hawthorne, Wayne J, Sureda, Anna, Orlando, Giuseppe, Haraldsson, Börje, Ascher, Nancy L, Dominguez-Gil, Beatriz, Oniscu, Gabriel C

“…Innovation is a hallmark of organ, tissue, and cell transplantation. The development of new treatments derived from these substances of human origin (SoHO) has…”
Get full text